Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 90Neoplasms, Plasma Cell 28Central Nervous System Neoplasms 11Recurrence 10Glioblastoma 10Neoplasms 9Carcinoma, Hepatocellular 9Brain Neoplasms 9Gliosarcoma 8Melanoma 6Lung Neoplasms 6Leukemia 6Glioma 6Carcinoma, Non-Small-Cell Lung 6Waldenstrom Macroglobulinemia 5Prostatic Neoplasms 5Lymphoma, Mantle-Cell 5Myeloproliferative Disorders 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Lymphocytic, Chronic, B-Cell 4Immunoglobulin Light-chain Amyloidosis 4Colorectal Neoplasms 4Carcinoma, Renal Cell 4Astrocytoma 4Uveal Melanoma 3Oligodendroglioma 3Neuroblastoma 3Myelodysplastic-Myeloproliferative Diseases 3Myelodysplastic Syndromes 3Medulloblastoma 3

Interventions

Cyclophosphamide 54Tacrolimus 50Methotrexate 36Mycophenolic Acid 34fludarabine phosphate 33Busulfan 31Cyclosporine 29fludarabine 28Antilymphocyte Serum 28Melphalan 23Sirolimus 21Whole-Body Irradiation 18Radiotherapy 18Peripheral Blood Stem Cell Transplantation 18Methylprednisolone 18Filgrastim 15thymoglobulin 13Thiotepa 10Stem Cell Transplantation 9Rituximab 9Granulocyte Colony-Stimulating Factor 8Hematopoietic Stem Cell Transplantation 7Etoposide 7Cord Blood Stem Cell Transplantation 7Cytarabine 6Alemtuzumab 6ruxolitinib 5Transplantation 5Therapeutics 5Prednisone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Graft vs Host Disease × Thalidomide × Clear all
NCT00003894 2011-03-07

Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant

Roswell Park Cancer Institute

Phase 2 Completed
36 enrolled

Graft vs Host Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡